Peptide YY (3-36)
- Generic Name
- Peptide YY (3-36)
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- -
- CAS Number
- 123583-37-9
- Unique Ingredient Identifier
- 7PQZ90ULIR
- Background
Peptide YY (3-36), a synthetic human PYY 3-36, is a compound being evaluated for the treatment of obesity. It reduces appetite and increases satiety in obese patients.
- Indication
Investigated for use/treatment in metabolic disease and obesity.
- Associated Conditions
- -
- Associated Therapies
- -
APPETITE: linguAl PYY3-36 on aPpEtite and acuTe Energy InTakE
- Conditions
- Interventions
- First Posted Date
- 2021-11-08
- Last Posted Date
- 2021-11-08
- Lead Sponsor
- University College, London
- Target Recruit Count
- 40
- Registration Number
- NCT05110664
A Study of Nasal PYY3-36 and Placebo for Weight Loss in Obese Subjects
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2007-10-01
- Last Posted Date
- 2008-09-15
- Lead Sponsor
- Nastech Pharmaceutical Company, Inc.
- Target Recruit Count
- 551
- Registration Number
- NCT00537420
- Locations
- 🇺🇸
For additional information regarding investigative sites for this trial, contact 1-425-415-3011, Salt Lake City, Utah, United States
Oral Administration of Peptides; Absorption From Gastrointestinal Tract
Phase 1
Completed
- Conditions
- First Posted Date
- 2007-05-03
- Last Posted Date
- 2008-10-17
- Lead Sponsor
- University Hospital, Basel, Switzerland
- Target Recruit Count
- 12
- Registration Number
- NCT00468884
- Locations
- 🇨ðŸ‡
Clinical Research Centre, University Hospital, Basel, Switzerland
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath